Modeling HIV-1 infection in the brain.
Colin T BarkerNaveen K VaidyaPublished in: PLoS computational biology (2020)
While highly active antiretroviral therapy (HAART) is successful in controlling the replication of Human Immunodeficiency Virus (HIV-1) in many patients, currently there is no cure for HIV-1, presumably due to the presence of reservoirs of the virus. One of the least studied viral reservoirs is the brain, which the virus enters by crossing the blood-brain barrier (BBB) via macrophages, which are considered as conduits between the blood and the brain. The presence of HIV-1 in the brain often leads to HIV associated neurocognitive disorders (HAND), such as encephalitis and early-onset dementia. In this study we develop a novel mathematical model that describes HIV-1 infection in the brain and in the plasma coupled via the BBB. The model predictions are consistent with data from macaques infected with a mixture of simian immunodeficiency virus (SIV) and simian-human immunodeficiency virus (SHIV). Using our model, we estimate the rate of virus transport across the BBB as well as viral replication inside the brain, and we compute the basic reproduction number. We also carry out thorough sensitivity analysis to define the robustness of the model predictions on virus dynamics inside the brain. Our model provides useful insight into virus replication within the brain and suggests that the brain can be an important reservoir causing long-term viral persistence.
Keyphrases
- antiretroviral therapy
- human immunodeficiency virus
- hiv infected
- hiv positive
- resting state
- hiv infected patients
- hepatitis c virus
- white matter
- hiv aids
- functional connectivity
- early onset
- cerebral ischemia
- sars cov
- hiv testing
- men who have sex with men
- end stage renal disease
- blood brain barrier
- chronic kidney disease
- multiple sclerosis
- bipolar disorder
- newly diagnosed
- data analysis
- machine learning
- brain injury
- disease virus